Icebreaker for the Iceberg Arriving!
Good News for MSers in Europe as Alemtuzumab/Lemtrada gets a
first line Licence
It is all about choice, I suspect we will see more of it in the future
Time to break the Iceberg
Labels:
Alemtuzumab
,
Lemtrada